The U.S. Federal Trade Commission (FTC) is conducting an ongoing investigation into Hims & Hers Health, Inc. regarding its advertising and subscription cancellation practices. The inquiry, which has been active for over a year, focuses on whether the company has made it unduly difficult for customers to cancel their subscriptions. Hims & Hers has acknowledged the FTC's inquiry, describing recent media reports as a rehash of the ongoing investigation and stating that it supports the FTC's efforts. The probe also includes complaints about the company's advertisements. Industry observers note that the FTC's investigation aligns with broader regulatory scrutiny of telehealth companies and their business practices.